Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tapestry
TPR
|
+$14.4M |
| 2 |
CNVR
CONVERSANT INC COM STK (DE)
CNVR
|
+$13.9M |
| 3 |
Pilgrim's Pride
PPC
|
+$12.6M |
| 4 |
WW
WW International
WW
|
+$12.1M |
| 5 |
URS
URS CORP
URS
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$26.5M |
| 2 |
GameStop
GME
|
+$16.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.1M |
| 4 |
Jabil
JBL
|
+$11.5M |
| 5 |
SGI
Somnigroup International
SGI
|
+$11.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.74% |
| 2 | Technology | 18.13% |
| 3 | Consumer Discretionary | 17.87% |
| 4 | Healthcare | 10.98% |
| 5 | Consumer Staples | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NWY
501
DELISTED
New York & Co Inc
NWY
| $1.53M | 0.05% |
265,518
+111,881
| +73% | +$653K |
|
|
SNTS
502
DELISTED
SANTARUS INC
SNTS
| $1.51M | 0.05% |
+66,922
| New | +$1.59M |
|
|
OMN
503
DELISTED
OMNOVA Solutions Inc.
OMN
| $1.5M | 0.05% |
175,852
+8,912
| +5% | +$72.8K |
|
504
Deckers Outdoor
DECK
$12.5B
| $1.5M | 0.05% |
136,686
-286,176
| -68% | -$2.78M |
|
|
SWI
505
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $1.49M | 0.05% |
42,600
+33,983
| +394% | +$1.33M |
|
|
AEGN
506
DELISTED
Aegion Corp
AEGN
| $1.49M | 0.05% |
62,590
+1,091
| +2% | +$25.3K |
|
507
Telus
TU
$15.6B
| $1.46M | 0.05% |
88,364
-94,778
| -52% | -$1.48M |
|
508
Genesco
GCO
$390M
| $1.46M | 0.05% |
+22,276
| New | +$1.52M |
|
509
HUB Group
HUBG
$2.49B
| $1.45M | 0.05% |
74,090
-35,124
| -32% | -$668K |
|
510
Saia
SAIA
$9.66B
| $1.45M | 0.05% |
46,606
-5,056
| -10% | -$157K |
|
|
STJ
511
DELISTED
St Jude Medical
STJ
| $1.45M | 0.05% |
27,075
-27,205
| -50% | -$1.4M |
|
512
Mistras Group
MG
$604M
| $1.44M | 0.05% |
+84,672
| New | +$1.48M |
|
513
Argan
AGX
$7.03B
| $1.43M | 0.05% |
65,170
+903
| +1% | +$15.8K |
|
514
Silicon Laboratories
SLAB
$7.27B
| $1.43M | 0.05% |
33,433
+28,039
| +520% | +$1.16M |
|
515
Invesco
IVZ
$14.1B
| $1.43M | 0.05% |
+44,692
| New | +$1.43M |
|
516
Carter's
CRI
$1.31B
| $1.42M | 0.05% |
18,763
+4,974
| +36% | +$364K |
|
517
Danaher
DHR
$154B
| $1.42M | 0.05% |
30,509
-8,387
| -22% | -$380K |
|
518
SPX Corp
SPXC
$10.4B
| $1.42M | 0.05% |
66,617
+45,197
| +211% | +$878K |
|
|
BRLI
519
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $1.41M | 0.05% |
47,324
-8,947
| -16% | -$249K |
|
|
DF
520
DELISTED
Dean Foods Company
DF
| $1.4M | 0.05% |
72,610
-319,464
| -81% | -$6.46M |
|
521
Donaldson
DCI
$10.8B
| $1.4M | 0.05% |
36,666
-19,496
| -35% | -$721K |
|
522
Ennis
EBF
$546M
| $1.39M | 0.05% |
77,218
+10,156
| +15% | +$185K |
|
523
J.M. Smucker
SJM
$13.3B
| $1.39M | 0.05% |
13,217
-8,503
| -39% | -$921K |
|
|
JNPR
524
DELISTED
Juniper Networks
JNPR
| $1.39M | 0.05% |
+69,836
| New | +$1.44M |
|
525
Advance Auto Parts
AAP
$2.57B
| $1.39M | 0.05% |
+16,753
| New | +$1.37M |
|
Similar funds
Joel Greenblatt's Q3 2013 Portfolio in Review
As of Q3 2013, Joel Greenblatt held 1,022 positions worth $3.08B, up 32% from $2.33B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Joel Greenblatt deployed $539M of net new capital in Q3 2013, opening 183 new positions and adding to 402 existing holdings. Its largest new stake was Pilgrim's Pride: 761,966 shares worth $12.8M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Wells Fargo, an estimated $26.5M trimmed.
- Joel Greenblatt's largest Q3 2013 buy was Pilgrim's Pride: 761,966 shares worth $12.8M.
- Joel Greenblatt added most to Tapestry in Q3 2013, an estimated $14.4M increase.
- Joel Greenblatt's biggest Q3 2013 reduction was Wells Fargo, cutting an estimated $26.5M.
- Joel Greenblatt fully exited SALIX PHARMACEUTICALS LTD DEL in Q3 2013, selling an estimated $8.43M.
- Joel Greenblatt's ten largest holdings make up 7.9% of its $3.08B portfolio in Q3 2013.
- Joel Greenblatt opened 183 new positions and closed 141 in Q3 2013.
- Joel Greenblatt's portfolio value rose 32% quarter-over-quarter to $3.08B.
Based on Gotham Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.